BMC Genomics 2008, 9:298 http://www.biomedcentral.com/1471-2164/9/298 Table 1: Transcripts differentially expressed between the procyclic and bloodstream forms of T. brucei. (Continued) Tb10.70.7410 VAMP (synaptobrevin) Tb10.389.0480 Vps16 Tb10.61.1910 Tb927.3.4000 Tb11.01.6880 *Tb11.50.0006 Tb11.01.6980 Tb927.8.7110 Tb10.70.2440 *Tb927.4.5310 *Tb10.70.5800 Tb927.6.1780 Tb927.4.3770 Tb10.61.2680 Tb10.61.2490 Tb10.70.1130 Tb11.46.0014 Tb09.211.3610 Tb927.6.2370 Tb927.4.2710 Tb927.2.6000 Tb11.01.3805 Tb09.211.4240 Tb10.70.4620 Tb927.4.2070 Tb927.6.3500 Tb11.01.4460 Tb927.5.4520 Tb927.5.3220 Tb11.01.6260 Tb927.1.1560 Tb10.70.5100 Tb11.02.1370 Tb927.4.2080 *Tb927.5.420 Tb927.5.310 *Tb927.8.4060 Tb10.61.1090 Tb10.406.0320 Tb927.5.630 Tb927.5.430 CLL AP1 sigma emp24 epsin-like protein PI3K (FYVE domain) Ser/Thr kinase NEK7-like (PH domain) PIK5KII Ser/Thr kinase A (PH domain) hexokinase (GCK/HK) MAP kinase (MAPK8/9) calcium-dependent protein kinase (CAMK4) pyruvate kinase (PKLR) MAP kinase kinase kinase (MAP3K8) two UIM domain-containing protein Doa4 (Ubiquitin C-term hydrolase) UBA2/E1 Ubiquitin-protein ligase E2 GPI-PLC CAP15 sorting nexin 2 (PX domain) gamma SNAP giantin RME-8 endosome trafficking scavenger receptor Uso1p-like (spectrin repeat) Sec11 Sec63 NSF lysosomal alpha-mannosidase katanin/Ser peptidase C2 domain-containing protein ISG65-like ISG-like fla2 (fla1-like) H3 variant ARPC5 ISG65-like ISG65-like ORFs represented by oligonucleotides on the array which gave a PCF to BSF expression ratio (panel A) or BSF to PCF expression (panel B) greater than two by limma or fpmsa analysis, or which had a value of over one for the B statistic in limma are shown. Limma ratios which correspond to a B value of >1 are given in bold. For candidates validated by qRT-PCR, the resulting qRT-PCR ratio is also given. Ratios below two may not be significant. The names of well-characterised genes which can be used as controls to validate the array results are in bold. Asterisk indicates oligonucleotides that hybridise with mRNA derived from more than one ORF [see Additional file 2]. 1.8 1.9 3.1 6.0 2.1 2.0 7.5 2.6 2.1 1.9 3.8 2.9 2.5 2.2 2.2 8.8 2.7 2.3 2.2 1.6 8.7 4.3 3.4 2.7 3.1 2.8 3.0 2.7 2.4 2.3 2.2 2.2 1.7 1.9 3.5 3.3 3.5 2.3 2.2 2.2 2.2 2.5 2.8 2.5 7.0 2.2 2.1 10.3 2.1 2.6 1.7 3.8 2.3 3.2 1.8 2.0 5.9 2.9 2.4 2.2 2.5 8.0 4.8 4.8 2.5 1.8 2.2 2.8 1.8 3.4 2.3 1.7 1.8 1.7 1.8 5.1 3.2 2.6 2.9 2.5 2.4 2.1 SNAREs Tethers 4.2 Vesicle coat Vesicle coat 1.7 Vesicle coat 2.5 Vesicle coat PI kinases PI kinases PI kinases PI kinases Other kinases Other kinases Other kinases Other kinases Other kinases Ubiquitin sorting Ubiquitin sorting 2.5 Ubiquitin sorting Ubiquitin sorting 1.6 Ubiquitin sorting Other trafficking Other trafficking Other trafficking Other trafficking Other trafficking 2.3 Other trafficking Other trafficking Other trafficking Other trafficking Other trafficking Other trafficking Other trafficking Other trafficking Other trafficking Miscellaneous Miscellaneous Miscellaneous 1.8 Miscellaneous Miscellaneous Miscellaneous Miscellaneous Page 7 of 28 (page number not for citation purposes)